MMX mesalamine/ mesalazine
SPD476-409
Approved small_molecule completed
Quick answer
MMX mesalamine/ mesalazine for Ulcerative Colitis is a Approved program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Ulcerative Colitis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed